You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm said it will dispute the claim of overpayment and will separately negotiate with the undisclosed payor for in-network status.
Stat News reports some health tech startups are laying off or furloughing workers.
CNBC discusses factors contributing to the state of direct-to-consumer genetic testing.
Ancestry is laying off about 6 percent of its workforce due to a decline in customer demand.
CEO Margo Georgiadis said that the company has "seen a slowdown in consumer demand across the entire DNA category."
Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.
The layoffs occurred across 23andMe's consumer business, which is being restructured, but did not impact its therapeutics business.
The New York Times reports the Infectious Disease Research Institute in Seattle has laid off about a third of its researchers.
In a Twitter message dated Dec. 4, the company said it is suspending its US operations for the time being "due to an unexpected adverse financing situation."
The firm disclosed to the state of California that it plans to lay off 42 employees in San Diego and 16 employees in Foster City.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.